Abstract
Drug-metabolizing enzymes (DMEs) and membrane transporters play important roles in the absorption, distribution, metabolism, and excretion processes that determine the pharmacokinetics of drugs. Inflammation has been shown to regulate the expression and function of these drug-processing proteins. Given that inflammation is a common feature of many diseases, in this review, the general mechanisms for inflammation-mediated regulation of DMEs and transporters are described. Also, evidences regarding the aberrant expression of these drug-processing proteins in several inflammatory diseases and age-related disorders are provided. © 2018
ScienceDirect Link
Recommended Citation
Wu, K.-C. and Lin, C.-J.
(2019)
"The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders,"
Journal of Food and Drug Analysis: Vol. 27
:
Iss.
1
, Article 3.
Available at: https://doi.org/10.1016/j.jfda.2018.11.005
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Fulltext URL
https://www.sciencedirect.com/science/article/pii/S1021949818301716/pdfft?md5=7216660392d75dd872066d016c037db4&pid=1-s2.0-S1021949818301716-main.pdf
Included in
Food Science Commons, Medicinal Chemistry and Pharmaceutics Commons, Pharmacology Commons, Toxicology Commons
Abstract Image